Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds SAQsadolescent-and-young-adult-medicine

Paeds SAQs · adolescent-and-young-adult-medicine

Adolescent risk assessment and harm minimisation — formative SAQs

Two formative short-answer questions on cross-domain adolescent risk assessment, validated screening, suicide safety, and a domain-specific harm-reduction bundle.

20 marks30 min3 min readVerification in progress

Target exams

RACP General PaediatricsRACP DWEMRCPCH TheoryMRCPCH ClinicalABP General Pediatrics
On this page
Study tools

Target exams

RACP General PaediatricsRACP DWEMRCPCH TheoryMRCPCH ClinicalABP General Pediatrics
Prompt
Adolescent risk assessment and harm minimisation

SAQ 1 — Cross-domain risk assessment (10 marks)

A 15-year-old presents with their parent for a sports medical. The parent answers every question. You secure time alone. The young person discloses occasional vaping, low mood for two weeks, and inconsistent condom use. [1] [3]

Questions

  1. Define harm minimisation and contrast it with an abstinence-only stance. (3 marks) [4]
  2. Outline how you would complete the risk assessment across all domains, naming the validated tools you would add where a lead appears. (4 marks) [1] [2] [5]
  3. Describe the brief-intervention method you would use and why it fits adolescent development. (3 marks) [7] [8]

Model answer

Harm minimisation vs abstinence (3). Harm minimisation is a pragmatic public-health stance that reduces the adverse consequences of a risk behaviour even when the behaviour continues; abstinence remains one possible goal but not the only acceptable outcome. Abstinence-only messaging demands the behaviour stop now and treats relapse as failure, which disengages the highest-risk youth. Harm reduction keeps young people alive and in contact enough for bigger change. [4]

Risk assessment (4). Complete HEADSS/HEEADSSS across all domains: Home, Education, Eating, Activities, Drugs, Sexuality, Suicide/mood/Safety, strengths. Add validated tools where a lead appears: CRAFFT or a frequency-based screen for the vaping/substance lead; a mood/suicide instrument (ASQ or Columbia) for the low-mood lead, then a full suicide risk assessment if positive; sexual-health history with STI testing to disclosed sites and a coercion question asked separately. Move from universal inquiry to selective screening to indicated assessment as the history drives it. [1] [2] [5]

Brief intervention (3). Use motivational interviewing — open questions, affirmation, reflective listening, summaries — to evoke the young person's own reasons for change rather than lecture. This fits the dual-systems model: the reward system outruns prefrontal control through mid-adolescence, so willpower-only demands fail and reducing consequences works with the biology. [7] [8]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References8ShowHide
  1. [1]Cohen E, Mackenzie RG, Yates GL HEADSS, a psychosocial risk assessment instrument: implications for designing effective intervention programs for runaway youth. Journal of adolescent health : official publication of the Society for Adolescent Medicine, 1991.PMID 1772892
  2. [2]Knight JR, Sherritt L, Shrier LA, Harris SK, Chang G Validity of the CRAFFT substance abuse screening test among adolescent clinic patients. Archives of pediatrics & adolescent medicine, 2002.PMID 12038895
  3. [3]Levy SJ, Williams JF Substance Use Screening, Brief Intervention, and Referral to Treatment. Pediatrics, 2016.PMID 27325634
  4. [4]Kimmel SD, Gaeta JM, Hadland SE, Hallett E, Marshall BDL Principles of Harm Reduction for Young People Who Use Drugs. Pediatrics, 2021.PMID 33386326
  5. [5]Horowitz LM, Bridge JA, Teach SJ, Ballard E, Klima J, Rosenstein DL Ask Suicide-Screening Questions (ASQ): a brief instrument for the pediatric emergency department. Archives of pediatrics & adolescent medicine, 2012.PMID 23027429
  6. [6]Chadi N, Hadland SE Youth Access to Naloxone: The Next Frontier? The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 2019.PMID 31648752
  7. [7]Cushing CC, Jensen CD, Miller MB, Leffingwell TR Meta-analysis of motivational interviewing for adolescent health behavior: efficacy beyond substance use. Journal of consulting and clinical psychology, 2014.PMID 24841861
  8. [8]Steinberg L A Social Neuroscience Perspective on Adolescent Risk-Taking. Developmental review : DR, 2008.PMID 18509515
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousAdolescent pregnancy and parenting — formative SAQsadolescent-and-young-adult-medicineNextAdolescent sexual health and contraception — formative SAQsadolescent-and-young-adult-medicine